Hankyel Park

Array ( [id] => 4151421 [patent_doc_number] => 06124132 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Use of anti-HIV IGA antibodies for producing immunological protection against the human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/916063 [patent_app_country] => US [patent_app_date] => 1997-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3460 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124132.pdf [firstpage_image] =>[orig_patent_app_number] => 916063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403953 [patent_doc_number] => 06271028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Hematopoietic cell method for treatment of HIV infection' [patent_app_type] => 1 [patent_app_number] => 8/910084 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1673 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271028.pdf [firstpage_image] =>[orig_patent_app_number] => 910084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361502 [patent_doc_number] => 06169175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Preparation and use of recombinant influenza A virus M2 construct vaccines' [patent_app_type] => 1 [patent_app_number] => 8/906930 [patent_app_country] => US [patent_app_date] => 1997-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 9227 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169175.pdf [firstpage_image] =>[orig_patent_app_number] => 906930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292137 [patent_doc_number] => 06197542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus' [patent_app_type] => 1 [patent_app_number] => 8/901379 [patent_app_country] => US [patent_app_date] => 1997-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 5 [patent_no_of_words] => 13447 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197542.pdf [firstpage_image] =>[orig_patent_app_number] => 901379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236894 [patent_doc_number] => 06075123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Cyclin-C variants, and diagnostic and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/867381 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 33597 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075123.pdf [firstpage_image] =>[orig_patent_app_number] => 867381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4231591 [patent_doc_number] => 06117652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Production of proteins by cell culture' [patent_app_type] => 1 [patent_app_number] => 8/856249 [patent_app_country] => US [patent_app_date] => 1997-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5010 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117652.pdf [firstpage_image] =>[orig_patent_app_number] => 856249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150717 [patent_doc_number] => 06113918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors' [patent_app_type] => 1 [patent_app_number] => 8/853826 [patent_app_country] => US [patent_app_date] => 1997-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43261 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113918.pdf [firstpage_image] =>[orig_patent_app_number] => 853826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087165 [patent_doc_number] => 06162897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => '17q-linked breast and ovarian cancer susceptibility gene' [patent_app_type] => 1 [patent_app_number] => 8/850727 [patent_app_country] => US [patent_app_date] => 1997-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 51483 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162897.pdf [firstpage_image] =>[orig_patent_app_number] => 850727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345777 [patent_doc_number] => 06214540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Chemokines that inhibit immunodeficiency virus infection and methods based thereon' [patent_app_type] => 1 [patent_app_number] => 8/826133 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22665 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214540.pdf [firstpage_image] =>[orig_patent_app_number] => 826133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936348 [patent_doc_number] => 05929222 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Expression of a foamy virus envelope protein' [patent_app_type] => 1 [patent_app_number] => 8/816439 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6948 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929222.pdf [firstpage_image] =>[orig_patent_app_number] => 816439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3972542 [patent_doc_number] => 05916685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Transparent high barrier multilayer structure' [patent_app_type] => 1 [patent_app_number] => 8/818116 [patent_app_country] => US [patent_app_date] => 1997-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 6 [patent_no_of_words] => 5167 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916685.pdf [firstpage_image] =>[orig_patent_app_number] => 818116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002060 [patent_doc_number] => 06004799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Recombinant live feline immunodeficiency virus and proviral DNA vaccines' [patent_app_type] => 1 [patent_app_number] => 8/811828 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 14007 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004799.pdf [firstpage_image] =>[orig_patent_app_number] => 811828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4128953 [patent_doc_number] => 06033886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Recombinant infectious non-segmented negative strand RNA virus' [patent_app_type] => 1 [patent_app_number] => 8/808130 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 11462 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033886.pdf [firstpage_image] =>[orig_patent_app_number] => 808130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992451 [patent_doc_number] => 05985636 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Method and compositions for inhibiting oxidation' [patent_app_type] => 1 [patent_app_number] => 8/799788 [patent_app_country] => US [patent_app_date] => 1997-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 6280 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985636.pdf [firstpage_image] =>[orig_patent_app_number] => 799788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406490 [patent_doc_number] => 06300057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Melanins with improved ability to inhibit HIV replication' [patent_app_type] => 1 [patent_app_number] => 8/796822 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7744 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300057.pdf [firstpage_image] =>[orig_patent_app_number] => 796822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831755 [patent_doc_number] => 05846546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses' [patent_app_type] => 1 [patent_app_number] => 8/788815 [patent_app_country] => US [patent_app_date] => 1997-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21382 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846546.pdf [firstpage_image] =>[orig_patent_app_number] => 788815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3776645 [patent_doc_number] => 05808096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Process for preparing active carbonates of polyalkylene oxides for modification of polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/785320 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5132 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808096.pdf [firstpage_image] =>[orig_patent_app_number] => 785320 [rel_patent_id] =>[rel_patent_doc_number] =>)